DJSG
BEAM icon

D.J. St. Germain’s Beam Therapeutics BEAM Stock Holding History

D.J. St. Germain’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.4K Hold
3,500
– – ﹤0.01% 387
2025
Q4 		$97K Buy
+3,500
New +$89.3K ﹤0.01% 404

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

D.J. St. Germain's BEAM Position: Q1 2026 in Review

D.J. St. Germain held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 3,500 shares worth $83.4K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

D.J. St. Germain first reported a position in BEAM in Q4 2025 and has held it in 2 quarters since. The position peaked at $97K in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • D.J. St. Germain held 3,500 shares of Beam Therapeutics worth $83.4K as of Q1 2026.
  • D.J. St. Germain left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of D.J. St. Germain's portfolio in Q1 2026, its #387 holding.
  • D.J. St. Germain first reported a position in Beam Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • D.J. St. Germain's Beam Therapeutics position peaked at $97K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.